Gilead Sprints To A Profit-Taking Zone After Riding Covid Drug To Beat And Raise
Gilead stock sprinted to a profit-taking zone Thursday after Gilead Sciences rode its Covid treatment to another beat and raise. Continue reading View comments
There is no Profile data available for GIS.DU.
86.46 | |
85.5 | |
- | |
86.46 | |
85.45 | |
55.9758-92.41 | |
78 028 M | |
0 | |
0 | |
0.0273 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Gilead stock sprinted to a profit-taking zone Thursday after Gilead Sciences rode its Covid treatment to another beat and raise. Continue reading View comments
Gilead Sciences rode its Covid treatment to a third-quarter beat and raise late Wednesday, and Gilead stock popped. Continue reading View comments
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: